Elidel-Study: Elidel in Patients With Atopic Dermatitis

Technische Universität Dresden24 enrolled

Overview

Atopic dermatitis is a common disease. Emollients and Elidel have both shown to be effective to treat this disease. The research question is, whether the effective component (Elidel) is better than the emollient to improve the skin function.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Atopic Dermatitis

Interventions

Elidel-CremeDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years * Atopic dermatitis on both lower arms at least 1% body surface area. * Atopic Dermatitis Severity Index (ADSI)-Score \>= 6 * Investigator Global Assessment (IGA)-Score \>= 2 Exclusion Criteria: * Systemic therapy with immunosuppressive drugs within the past 24 weeks * Phototherapy against atopic dermatitis. * Antibiotic therapy against atopic dermatitis. * Allergy against Elidel. * Pregnancy * Nursing * Skin cancer

Locations (1)

Technical University Dresden

Dresden, Saxony, Germany

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.